Get the Latest Whitepapers & Research Updates.

Unlock exclusive scientific insights! Sign up for our newsletter to stay updated on the latest whitepapers, application notes, case studies, and more. Gain early access to new research resources and stay informed about industry trends, upcoming webinars, and product innovations from Leinco Technologies.

Rabbit mAb Development Whitepaper

A white paper that describes our proprietary process of developing and producing rabbit monoclonal antibodies.

Biosimilars Whitepaper

Explore how high-purity, research-grade biosimilars support the development of cost-effective biotherapeutics. This whitepaper highlights Leinco’s recombinant biosimilars, designed for reliable data generation.

Recombinant Human Infectious Disease mAbs Monograph Download

This monograph explores their role in rapid diagnostics, surveillance, and research. Download now to learn more about Leinco’s antibody screening and assay development services.

Henipavirus (Nipah) & Rotavirus Application Note

Explore the latest advancements in diagnostic tools with Leinco’s Rapid Antibody Screening Report on Henipavirus (Nipah) and Rotavirus. Learn how our high-sensitivity, high-specificity antibodies enhance detection and diagnostic accuracy.

In Vivo Case Study

This case study highlights superior efficacy, reproducibility, and cost-efficiency in tumor growth experiments.

Spatial Biology Application Note

This application note highlights key immune cell interactions in tumor progression and response to checkpoint therapy.

Spatial Biology Whitepaper

This whitepaper explores how the need for context and interaction has driven the development of spatial biology for multidimensional cellular analysis.

Influenza Assay Development

A case study that explores how we identified the best Influenza A matched pairs for a rapid lateral flow device.

Immunology and Oncology Ebook

Discover key immune checkpoint targets and the latest trends in immuno-oncology research with our comprehensive eBook. Explore biomarkers, emerging targets, and in vivo antibody applications to advance cancer research.